Alzheimer's disease

News

Anavex sinks after pulling Alzheimer's filing in EU

Shares in Anavex Life Sciences lost more than a third of their value today after the company abandoned an EU filing for its Alzheimer's therapy.

News

Appeal finds NICE must reconsider Alzheimer's drugs

Lilly and Eisai's bid to secure NHS coverage of their Alzheimer's therapies has entered a new phase, after an appeal of last year's rejection by NICE.

News

Could Alzheimer's be predicted with a finger-prick test?

An international trial has started to see if a simple finger-prick blood test could predict Alzheimer's before symptoms start.

News

Disappointment as Novo's oral GLP-1 fails in Alzheimer's

GLP-1 agonists have been shown to be beneficial in a lengthening list of diseases, but it seems Alzheimer's disease may not be among them.

News

J&J abandons Alzheimer's antibody in setback for tau

Hopes that anti-tau drugs could emerge as treatments for Alzheimer's have been dented by the failure of a phase 2b trial of J&J's posdinemab.

News

FDA clears Roche, Lilly Alzheimer's blood test

A blood test developed by Roche and Eli Lilly that could help diagnose patients with Alzheimer's more quickly has been approved by the FDA.

Anavex sinks after pulling Alzheimer's filing in EU

Appeal finds NICE must reconsider Alzheimer's drugs

Could Alzheimer's be predicted with a finger-prick test?

Disappointment as Novo's oral GLP-1 fails in Alzheimer's

J&J abandons Alzheimer's antibody in setback for tau

FDA clears Roche, Lilly Alzheimer's blood test

LSX2026: On promise and patience, with Hans Schambye

Using AI-driven synthetic personas to take your insights fur...

Alzheimer's disease

Editor's Picks